Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Conditions: Invasive Mammary Carcinoma; Metastatic Breast Cancer Interventions: Drug: Capecitabine; Other: Endocrine-therapy; Other: MammoPrint ® and BluePrint assays Sponsors: Sonya Reid; Agendia; Susan G. Komen Breast Cancer Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Endocrine Therapy | Genetics | Research | Xeloda